Alzheimer Disease, Late Onset
24
6
8
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 24 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (24)
Reducing Risk of Dementia Through Deprescribing
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
China Cognition and Aging Study
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease
Effects of Personalized Music Listening in Advanced Alzheimer's
Multimodal Assesment of Alzheimer Patients
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease
Transcranial Electromagnetic Treatment Against Alzheimer's Disease
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?
NYSCF Scientific Discovery Biobank
Genetic Studies in Familial Dementia
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior
Network-based rTMS in Alzheimer's Disease
Tdap and Biomarkers of Alzheimer's Disease
Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care
BCG and Plasma Amyloid in Non-Demented Adults
Synaptic Injury and Functional Connectivity in Alzheimer's Disease